Cases & Deals

Shanghai Zhenge Biotech raises $51 million in Series A round

Clients Shanghai Zhenge Biotech Co., Ltd.

Jones Day represented Shanghai Zhenge Biotech Co., Ltd., a Shanghai-based CDMO (“Contract Development and Manufacturing Organization”) company for biotech companies developing antibodies and other protein drugs, in connection with the $51 million Series A round of financing led by LYFE Capital.